Mechanistically, aromatase-induced oestrogen promotes the binding of ERα to the ERE in the matrix metalloproteinase 12 promoter upon bicalutamide treatment in PCa cells, leading to CRPC progression [11]. The gene discussed is MMP12; the disease is posterior cortical atrophy.